Solara Active Pharma Sciences Limited (SOLARA) — Cash Flow-to-Debt Ratio
Solara Active Pharma Sciences Limited (SOLARA) has a Cash Flow-to-Debt Ratio of 0.07x as of September 2025, meaning its operating cash flow of Rs740.70 Million could theoretically repay 0% of its total liabilities (Rs10.36 Billion) in one year. See Solara Active Pharma Sciences Limited free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Solara Active Pharma Sciences Limited Cash Flow-to-Debt Ratio (2017–2025)
Historical debt coverage capacity for Solara Active Pharma Sciences Limited across 9 annual periods. Also explore Solara Active Pharma Sciences Limited (SOLARA) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Solara Active Pharma Sciences Limited (2017–2025)
Year-by-year debt coverage analysis for Solara Active Pharma Sciences Limited. For market capitalisation and broader financial context, see Solara Active Pharma Sciences Limited market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (INR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.19x | Rs2.13 Billion | Rs11.35 Billion | ▲ +143.6% |
| 2024 | 0.08x | Rs1.09 Billion | Rs14.14 Billion | ▼ -31.2% |
| 2023 | 0.11x | Rs1.56 Billion | Rs13.97 Billion | ▲ +165.5% |
| 2022 | -0.17x | Rs-2.42 Billion | Rs14.18 Billion | ▼ -212.1% |
| 2021 | 0.15x | Rs1.55 Billion | Rs10.21 Billion | ▼ -33.7% |
| 2020 | 0.23x | Rs2.44 Billion | Rs10.63 Billion | ▲ +43.6% |
| 2019 | 0.16x | Rs1.60 Billion | Rs10.00 Billion | ▲ +242.1% |
| 2018 | 0.05x | Rs492.23 Million | Rs10.53 Billion | ▼ -100.0% |
| 2017 | 14916.06x | Rs492.23 Million | Rs33.00K | — |